In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration

Movement Disorders : Official Journal of the Movement Disorder Society
Alexander GerhardDavid J Brooks

Abstract

Corticobasal degeneration (CBD) is a neurodegenerative parkinsonian disorder of unknown cause that shows considerable clinical heterogeneity. In CBD, activated microglia have been shown to be associated closely with the extensive tau pathology found in the affected basal ganglia, brainstem nuclei, and cortical regions. We report on the use of [(11)C](R)-(1-[2-chlorophenyl]-N-methyl-N-[1-methylpropyl]-3-isoquinoline carboxamide) (PK11195) positron emission tomography (PET), a marker of peripheral benzodiazepine binding sites (PBBS) that are expressed by activated microglia, to demonstrate in vivo the degree and distribution of glial response to the degenerative process in 4 patients with CBD. Compared with normal age-matched controls, the CBD patient group showed significantly increased mean [(11)C](R)-PK11195 binding in the caudate nucleus, putamen, substantia nigra, pons, pre- and postcentral gyrus, and the frontal lobe. [11C](R)-PK11195 PET reveals a pattern of increased microglial activation in CBD patients involving cortical regions and the basal ganglia that corresponds well with the known distribution of neuropathological changes, which may therefore help to characterize in vivo the underlying disease activity in CBD.

References

Jan 1, 1968·Archives of Neurology·J J RebeizE P Richardson
Jan 1, 1994·Developmental Neuroscience·R B Banati, M B Graeber
Aug 1, 1996·Trends in Neurosciences·G W Kreutzberg
Apr 1, 1997·Neurology·J A SchneiderS S Mirra
Sep 29, 2000·Physics in Medicine and Biology·T J SpinksR Nutt
May 11, 2001·Seminars in Neurology·N P Stover, R L Watts
Jun 12, 2001·Journal of Neuropathology and Experimental Neurology·K Ishizawa, D W Dickson
Aug 22, 2001·Lancet·A CagninR B Banati
Oct 16, 2002·Glia·Richard B Banati
Nov 15, 2002·Journal of Neuropathology and Experimental Neurology·D W DicksonUNKNOWN Office of Rare Diseases of the National Institutes of Health

❮ Previous
Next ❯

Citations

Dec 5, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Sriram VennetiJulia Kofler
Oct 22, 2013·Current Neurology and Neuroscience Reports·Alexander Gerhard
Jun 30, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Annachiara CagninRichard B Banati
Sep 12, 2009·Journal of Child Neurology·Sujatha KannanDiane Chugani
Jan 13, 2006·International Review of Psychiatry·Paul B Rosenberg
Sep 14, 2014·Journal of Neuroinflammation·Petra MajerovaMichal Novak
Jan 16, 2016·Journal of Viral Hepatitis·H PflugradK Weissenborn
Sep 19, 2008·Journal of Neuropathology and Experimental Neurology·Sriram VennetiClayton A Wiley
Jun 16, 2009·Behavioural Brain Research·Susanne NikolausHans-Wilhelm Müller
Dec 22, 2015·Seminars in Nuclear Medicine·Laura B EisenmengerJames M Mountz
Apr 1, 2008·Pharmacology & Therapeutics·Ming-Kai Chen, Tomás R Guilarte
Dec 3, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·James VarleyPaul Edison
Jul 27, 2006·Acta Neurologica Scandinavica. Supplementum·A CagninR B Banati
Jun 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Anna L Bartels, Klaus L Leenders
Jun 1, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Gregor K WenningEduardo Tolosa
Jun 1, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·A Jon StoesslDavid Eidelberg
Oct 15, 2013·Neuropathology and Applied Neurobiology·Suzannah B LantDavid M A Mann
Sep 18, 2015·Journal of Neuroinflammation·Dianne E LeeDima A Hammoud
Jun 24, 2014·Lancet·A Jon StoesslAntonio P Strafella
Jun 25, 2016·Clinical and Translational Imaging : Reviews in Nuclear Medicine and Molecular Imaging·Alexander Gerhard
Apr 3, 2015·Brain : a Journal of Neurology·Nicole MaphisKiran Bhaskar
Jun 20, 2015·Frontiers in Neuroscience·Nicole MaphisKiran Bhaskar
May 14, 2008·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Masahiro Mishina
Jul 30, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Flavia Niccolini, Marios Politis
May 6, 2017·International Journal of Molecular Sciences·Chiara CeramiDaniela Perani
Apr 8, 2017·International Journal of Molecular Sciences·Anne-Claire DupontNicolas Arlicot
May 19, 2017·Journal of Neural Transmission·Julien LagardeMichel Bottlaender
Sep 27, 2005·Neurobiology of Disease·Alexander GerhardDavid J Brooks
Feb 22, 2007·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Alie SchuitemakerRonald Boellaard
Oct 13, 2017·Expert Review of Neurotherapeutics·Kurt A Jellinger
Mar 31, 2016·World Journal of Radiology·Karlo J LizarragaAntonio A De Salles
Oct 27, 2017·F1000Research·Leonardo IaccarinoDaniela Perani
Aug 19, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Alexander GerhardDavid J Brooks
Mar 3, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Marc A KrophollerAdriaan A Lammertsma
Jul 7, 2019·Acta Neuropathologica Communications·Thomas VogelsTomáš Hromádka
Jul 8, 2017·Current Medicinal Chemistry·Balazs SzatmariMaria Judit Molnar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Alexander GerhardDavid J Brooks
Movement Disorders : Official Journal of the Movement Disorder Society
Karsten HenkelG Bernhard Landwehrmeyer
© 2021 Meta ULC. All rights reserved